2012-10-10 01:06:52 - Fast Market Research recommends "Mycobacterium Tuberculosis Infections - Pipeline Review, H2 2012" from Global Markets Direct, now available

Global Markets Direct's, 'Mycobacterium Tuberculosis Infections - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Mycobacterium Tuberculosis Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Mycobacterium Tuberculosis Infections. Mycobacterium Tuberculosis Infections - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.


Full Report Details at
- www.fastmr.com/prod/468438_mycobacterium_tuberculosis_infections ..


Note*: Certain

sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

* A snapshot of the global therapeutic scenario for Mycobacterium Tuberculosis Infections.
* A review of the Mycobacterium Tuberculosis Infections products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Mycobacterium Tuberculosis Infections pipeline on the basis of route of administration and molecule type.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Mycobacterium Tuberculosis Infections.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Mycobacterium Tuberculosis Infections pipeline depth and focus of Indication therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Mycobacterium Tuberculosis Infections Overview
Therapeutics Development
An Overview of Pipeline Products for Mycobacterium Tuberculosis Infections
Mycobacterium Tuberculosis Infections Therapeutics under Development by Companies
Mycobacterium Tuberculosis Infections Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Discovery and Pre-Clinical Stage Products
Comparative Analysis
Mycobacterium Tuberculosis Infections Therapeutics - Products under Development by Companies
Mycobacterium Tuberculosis Infections Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Mycobacterium Tuberculosis Infections Therapeutics Development
Johnson & Johnson
Sequella, Inc.
AlphaRx, Inc.
AstraZeneca PLC
GlaxoSmithKline plc
FASgen, Inc.
Emergent BioSolutions Inc.
Achillion Pharmaceuticals, Inc.
Pfizer Inc.
Vertex Pharmaceuticals Incorporated
AVI BioPharma Inc.
Crucell N.V.
Affinium Pharmaceuticals, Inc.
Intercell AG
Lupin Limited
Albert Einstein College of Medicine of Yeshiva University
Summit Corporation plc
PolyMedix, Inc.
Immune Network Research Ltd.
Snowdon Inc.
ImmunoBiology Limited
Recipharm AB
MicuRx Pharmaceuticals, Inc.
ApoImmune, Inc.
Mondobiotech Holding AG
EpiVax, Inc.
Archivel Farma S.L.
Canopus BioPharma Incorporated
Avir Green Hills Biotechnology AG
TVAX Biomedical, LLC
Medisyn Technologies, Inc.
Vakzine Projekt Management GmbH
ISA Pharmaceuticals B.V.
Lipotek Pty Ltd
Mycobacterium Tuberculosis Infections - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
delamanid - Drug Profile
delamanid - Drug Profile
streptomycin - Drug Profile
SND-159 - Drug Profile
PMX-10072 - Drug Profile
bedaquiline - Drug Profile
SQ-109 - Drug Profile
MVA-85A - Drug Profile
Tuberculosis vaccine - Drug Profile
ApoVax-104-TB Vaccine - Drug Profile
rifalazil - Drug Profile
SQ-609 - Drug Profile
NasL3/HtkBCG - Drug Profile
rBCG T+B rM. Smegmatis T+B - Drug Profile
MTBVAC01 - Drug Profile
FAS-20013 - Drug Profile
sutezolid - Drug Profile
VPM-1002 - Drug Profile
HG85-A/B - Drug Profile
HG856-A - Drug Profile
VecFlu - Drug Profile
PS-Conjugate Vaccine - Drug Profile
BCG Danish Attenuated Recombinant Live Vaccine - Drug Profile
GSK-692342 - Drug Profile
R32kDa BCG Protein / R32Kda - Drug Profile
r30 - Drug Profile
TB Vaccine - Drug Profile
linezolid - Drug Profile
isoniazid - Drug Profile
TB proteasome inhibitor program - Drug Profile
HBHA - Drug Profile
streptomyces live vector - Drug Profile
rBCG(mbtB)30 - Drug Profile
sudoterb - Drug Profile
rifapentine - Drug Profile
Ad5Ag85A - Drug Profile
metronidazole - Drug Profile

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=468438&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.